Skip to content
10-Q

Quarterly Report

Vaccinex, Inc. VCNX

0000950170-24-127139

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 12, 2024 2.6M sh
Shares Diluted Q3 2024 · Sep 30, 2024 2.03M sh
Shares Diluted Q3 2024 · Sep 30, 2024 1.72M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 322.15K sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 282.47K sh
Capex Q3 2024 · Sep 30, 2024 $22K
Capex Q3 2024 · Sep 30, 2023 $67K
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$12.25M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$13.64M
Short Term Debt Q3 2024 · Sep 30, 2024 $44K
Short Term Debt Q3 2024 · Dec 31, 2023 $75K
Cash And Equivalents Q3 2024 · Sep 30, 2024 $2.91M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $1.54M
Current Liabilities Q3 2024 · Sep 30, 2024 $6.18M
Current Liabilities Q3 2024 · Dec 31, 2023 $5.92M
Total Liabilities Q3 2024 · Sep 30, 2024 $6.18M
Total Liabilities Q3 2024 · Dec 31, 2023 $5.94M
Current Assets Q3 2024 · Sep 30, 2024 $4.76M
Current Assets Q3 2024 · Dec 31, 2023 $3.35M
Total Assets Q3 2024 · Sep 30, 2024 $4.85M
Total Assets Q3 2024 · Dec 31, 2023 $3.63M
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.83
Eps Diluted Q3 2024 · Sep 30, 2024 −$8.85
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$15.25
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$59.95
Eps Basic Q3 2024 · Sep 30, 2024 −$2.83
Eps Basic Q3 2024 · Sep 30, 2024 −$8.85
Eps Basic restated Q3 2024 · Sep 30, 2023 −$15.25
Eps Basic restated Q3 2024 · Sep 30, 2023 −$59.95
Sga Expense Q3 2024 · Sep 30, 2024 $1.44M
Sga Expense Q3 2024 · Sep 30, 2024 $5.32M
Sga Expense Q3 2024 · Sep 30, 2023 $1.5M
Sga Expense Q3 2024 · Sep 30, 2023 $5.25M
Rd Expense Q3 2024 · Sep 30, 2024 $3.17M
Rd Expense Q3 2024 · Sep 30, 2024 $10.41M
Rd Expense Q3 2024 · Sep 30, 2023 $4.36M
Rd Expense Q3 2024 · Sep 30, 2023 $13.22M
Net Income Q3 2024 · Sep 30, 2024 −$5.73M
Net Income Q3 2024 · Sep 30, 2024 −$15.26M
Net Income Q3 2024 · Sep 30, 2023 −$4.91M
Net Income Q3 2024 · Sep 30, 2023 −$16.93M
Operating Income Q3 2024 · Sep 30, 2024 −$4.55M
Operating Income Q3 2024 · Sep 30, 2024 −$15.35M
Operating Income Q3 2024 · Sep 30, 2023 −$5.83M
Operating Income Q3 2024 · Sep 30, 2023 −$17.9M
Revenue Q3 2024 · Sep 30, 2024 $52K
Revenue Q3 2024 · Sep 30, 2024 $388K
Revenue Q3 2024 · Sep 30, 2023 $20K
Revenue Q3 2024 · Sep 30, 2023 $570K
Long Term Debt Q3 2024 · Dec 31, 2023 $26K